CNIPA.AI
검색으로 돌아가기
기록

BIOMARKERS OF FIBROSIS AND USES THEREFOR

발명심사 중
17청구항 · 10 독립항
§ Ⅰ

개요

발명자

Chamindie Punyadeera; Darrell Crawford

IPC 분류

G1N 33/68C12Q 1/34C12Q 1/527

CPC 분류

G1N33/6893C12Q1/34C12Q1/527G1N2333/4703G1N2333/4713G1N2333/8146G1N2333/918G1N2333/988G1N2400/40G1N2800/85G1N2800/52G1N2800/56

The present disclosure relates generally to biomarkers of fibrosis. More particularly, the present disclosure relates to salivary biomarkers and their use in methods, apparatuses, compositions and kits for determining an indicator that is useful for assessing a likelihood of a presence, absence or degree of liver fibrosis in a human subject. In particular embodiments, the disclosed methods, apparatuses, compositions and kits are used to determine an indicator for assessing a likelihood of a presence, absence or development of liver cirrhosis in a subject.

원문 (중국어)

The present disclosure relates generally to biomarkers of fibrosis. More particularly, the present disclosure relates to salivary biomarkers and their use in methods, apparatuses, compositions and kits for determining an indicator that is useful for assessing a likelihood of a presence, absence or degree of liver fibrosis in a human subject. In particular embodiments, the disclosed methods, apparatuses, compositions and kits are used to determine an indicator for assessing a likelihood of a presence, absence or development of liver cirrhosis in a subject.